| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $18,025,406 ) (Continued on the next page) |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA260449 | Exploiting gold nanoparticle as a probe to identify therapeutic targets | 000 | 4 | NIH | 11/20/2024 | $319,463 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | K01MD015295 | HealthyCells: A Culturally-Tailored Smoking Cessation Smartphone Intervention for African Americans with Adjunctive Treatment for Sedentary Behavior | 000 | 5 | NIH | 2/18/2025 | $121,243 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R37AI037657 | Pore Formation by Cholesterol Dependent Cytolysins | 000 | 29 | NIH | 4/23/2025 | $475,153 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | F31AI179208 | Toxin B receptor mediated events in Clostridioides difficile disease | 000 | 2 | NIH | 1/10/2025 | $36,574 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | F31DK137568 | Targeting kidney resident macrophage niche filling to slow cystic kidney disease | 000 | 2 | NIH | 4/10/2025 | $37,439 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | T32EY023202 | Vision Science Training Program | 000 | 10 | NIH | 4/9/2025 | $67,832 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | OT2OD038371 | Primary Care Research in More Environments in Oklahoma (PRIME-OK) | 001 | 1 | NIH | 4/11/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | OT2OD038371 | Primary Care Research in More Environments in Oklahoma (PRIME-OK) | 000 | 1 | NIH | 1/17/2025 | $1,260,980 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA297076 | Protein-nanoparticle interaction to study multicellular crosstalk within ovarian tumor microenviroment | 000 | 1 | NIH | 1/16/2025 | $326,103 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R13HD117635 | Be Curious, Not Judgmental: The 4th National Symposium on Sexual Behavior of Youth | 001 | 1 | NIH | 3/26/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R13HD117635 | Be Curious, Not Judgmental: The 4th National Symposium on Sexual Behavior of Youth | 000 | 1 | NIH | 1/20/2025 | $10,000 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA298165 | A Randomized Factorial Trial of Varenicline with Nicotine Lozenges and a Smartphone Medication Adherence Intervention to Promote Smoking Cessation | 000 | 1 | NIH | 12/17/2024 | $625,201 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01HL161008 | Biomarker-guided optimization of transcutaneous vagal stimulation for atrial fibrillation | 000 | 4 | NIH | 12/19/2024 | $379,891 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | F31AI189149 | Human gut Bacteroidales defense mechanisms against emerging antibacterial toxins | 001 | 1 | NIH | 11/20/2024 | $0 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | F31AI189149 | Human gut Bacteroidales defense mechanisms against emerging antibacterial toxins | 000 | 1 | NIH | 11/20/2024 | $46,402 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | H7600185 | Ryan White Part C Outpatient EIS Program | 02 | 29 | HRSA | 5/7/2025 | $219,894 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | H7600185 | Ryan White Part C Outpatient EIS Program | 01 | 29 | HRSA | 3/6/2025 | -$293,192 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | H7600185 | Ryan White Part C Outpatient EIS Program | 00 | 29 | HRSA | 12/4/2024 | $293,192 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01EY033499 | Targeting Surfactant Protein A to Prevent Retinopathy of Prematurity | 000 | 2 | NIH | 4/7/2025 | $475,611 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | UG3CA290310 | Discovery and Development of Natural Products for Interception of CRC | 000 | 2 | NIH | 4/14/2025 | $273,488 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R03CA289562 | Role of JMJD4 in Breast Cancer | 000 | 2 | NIH | 2/13/2025 | $72,500 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | H3306689 | EMSC Partnership Grants | 00 | 20 | HRSA | 3/19/2025 | $85,110 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | UG1CA287044 | Oklahoma Tribal, Rural, Urban Cancer Screening Trial ACCESS Hub | 001 | 2 | NIH | 4/14/2025 | $450,450 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | UG1CA287044 | Oklahoma Tribal, Rural, Urban Cancer Screening Trial ACCESS Hub | 000 | 2 | NIH | 12/5/2024 | $738,924 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA255840 | Chemotherapy-induced vascular cognitive impairment: role of endothelial senescence | 000 | 5 | NIH | 12/17/2024 | $298,519 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AG083950 | Therapeutic Potential of FGF21 for Alzheimer's Disease | 003 | 3 | NIH | 5/2/2025 | $269,870 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AG083950 | Therapeutic Potential of FGF21 for Alzheimer's Disease | 000 | 3 | NIH | 4/18/2025 | $488,913 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AI185203 | Targeting chondroitin sulfate proteoglycan 4 (CSPG4) expression as a Clostridioides difficile therapeutic | 000 | 2 | NIH | 4/14/2025 | $357,500 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK131064 | Sulfur Amino Acid Metabolism and Regulation of Hepatic Metabolic Flexibility | 000 | 4 | NIH | 12/13/2024 | $370,911 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01EY034133 | Correction of diabetic retinopathy by mitochondrial transfer | 001 | 3 | NIH | 4/2/2025 | $554,407 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R21EY035725 | Targeting Innate Inflammation Pathways to Treat Ocular Infections | 000 | 2 | NIH | 12/20/2024 | $217,500 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK139443 | Evaluating PQQ for preventing maternal obesity-induced fetal programming of juvenile NAFLD in Papio anubis | 000 | 2 | NIH | 3/5/2025 | $559,845 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01HD109784 | Prevention of Necrotizing Enterocolitis | 001 | 3 | NIH | 4/14/2025 | $40,935 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01HD109784 | Prevention of Necrotizing Enterocolitis | 000 | 3 | NIH | 1/24/2025 | $368,415 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01HL169530 | Mechanism of F-18-fluorodeoxyglucarate accrual in myocardial injury | 000 | 2 | NIH | 4/3/2025 | $362,500 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01EY033841 | Thyroid Hormone Signaling and Cone Photoreceptor Degeneration | 000 | 4 | NIH | 4/10/2025 | $364,637 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R00GM141267 | Identification of novel osmosensing receptors in C. elegans | 000 | 4 | NIH | 1/21/2025 | $224,100 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AI154274 | Cellular Mechanism of Oxysterol-Binding Protein (OSBP) in Viral Proliferation: A Chemical Biology Approach | 000 | 5 | NIH | 4/11/2025 | $390,514 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | K01DA055073 | Identifying and Addressing the Effects of Social Media Use on Young Adults' E-Cigarette Use: A Solutions-Oriented Approach | 000 | 3 | NIH | 1/9/2025 | $198,612 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DA053342 | Beta-Adrenergic Modulation of Drug Cue Reactivity: Neural and Behavioral Mechanisms | 000 | 4 | NIH | 3/21/2025 | $525,353 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DA053342 | Beta-Adrenergic Modulation of Drug Cue Reactivity: Neural and Behavioral Mechanisms | 001 | 4 | NIH | 4/11/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AT012165 | The Oklahoma Study of Native American Pain Risk: Stress and Resilience Mechanisms | 000 | 4 | NIH | 4/25/2025 | $463,325 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DA060878 | Using Real Time Data to Examine the Impact of Product Characteristics on Young Adult ENDS Use | 000 | 1 | NIH | 4/23/2025 | $602,496 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA251451 | Mobile Contingency Management for Smoking Cessation among Socioeconomically Disadvantaged Adults | 000 | 5 | NIH | 4/9/2025 | $547,259 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA253391 | Normalizing aberrant metabolism in ovarian cancer by a unique drug delivery system | 000 | 5 | NIH | 1/8/2025 | $330,560 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01EY028608 | Caveolae-Based Mechanosensors for Conventional Outflow Regulation | 000 | 6 | NIH | 3/13/2025 | $604,777 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01EY030766 | Anti-ceramide immunotherapy for diabetic retinopathy | 001 | 5 | NIH | 4/4/2025 | $422,886 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R56DK139005 | NR2F2 Pioneers Neonatal Beige Adipogenesis to Protect Against Later-life Obesity | 000 | 1 | NIH | 3/28/2025 | $107,250 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK134316 | Novel Roles of Cullin-RING E3 Ligases in Liver Pathophysiology | 000 | 3 | NIH | 2/17/2025 | $353,583 |
|
